...
首页> 外文期刊>Military Medicine: Official Journal of AMSUS, The Society of the Federal Health Agencies >Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training.
【24h】

Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training.

机译:短暂的半衰期催眠药可在军事山区训练期间保持身体健康和高度耐受性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We study the effect of short half-life hypnotics (zaleplon or zolpidem against placebo) on altitude tolerance in 12 nonacclimated male soldiers (age, 22.1 +/- 0.8 years; height, 177.8 +/- 1.7 cm; weight, 69.8 +/- 1.7 kg). METHODS: Soldiers were trained to practice mountaineering at high altitude (2,533-4,810 meters) during 3 periods (one per medication tested) of 4 days (D1-D4). In each period the nights were spent in a hut (3,613 m). Administration of hypnotics or placebo was then implemented at 9:45 p.m. Nocturnal arterial oxygen saturation (SaO2) and heart rate variability (HRV) were monitored. At 5:00 a.m. and 9:00 p.m. physical fitness was assessed using acute mountain sickness (AMS) score. At 5:00 p.m., a posteffort stand test was carried out to evaluate the orthoparasympathetic imbalance with fatigue. RESULTS: Nocturnal SaO2 correlated negatively with morning AMS scores (R = -0.820, p < 0.02) and HRV analysis favored the sympathetic modulation. Posteffort stand tests revealed that sympathetic modulation attenuated from D2 to D3 in treated groups. CONCLUSION: The present study provides evidence that zolpidem or zaleplon improves sleep and subsequent physical fitness at altitude.
机译:目的:我们研究了半衰期短的催眠药(zaleplon或唑吡坦对安慰剂的作用)对12名未适应的男性士兵(年龄,22.1 +/- 0.8岁;身高,177.8 +/- 1.7 cm;体重,69.8 +)的海拔耐受性的影响/-1.7公斤)。方法:对士兵进行了训练,可以在4天(D1-D4)的3个时期(每种药物测试一个)中进行高海拔(2,533-4,810米)的登山练习。在每个时期中,夜晚都在小屋(3,613 m)中度过。然后在晚上9:45实施催眠药或安慰剂的给药。监测夜间动脉血氧饱和度(SaO2)和心率变异性(HRV)。在上午5:00和下午9:00使用急性高山病(AMS)评分评估身体素质。下午5:00,进行了努力后的站立测试,以评估伴疲劳的正副交感神经失衡。结果:夜间SaO2与早晨AMS评分呈负相关(R = -0.820,p <0.02),HRV分析偏向于交感神经调节。努力后的站立测试显示,在治疗组中,交感调节从D2减弱到D3。结论:本研究提供了唑吡坦或扎来普隆改善睡眠和随后的高原身体健康的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号